(Q33688754)

28 July 2017

Willingness to use tamoxifen to prevent breast cancer among diverse women (English)

1 reference

28 July 2017

1 reference

Celia Patricia Kaplan

1

1 reference

28 July 2017

Sue E Kim

2

1 reference

28 July 2017

Sabrina T Wong

3

1 reference

28 July 2017

George F Sawaya

4

1 reference

28 July 2017

Judith M E Walsh

5

1 reference

28 July 2017

Eliseo J Pérez-Stable

6

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 May 2012

1 reference

Breast Cancer Research and Treatment

28 July 2017

1 reference

28 July 2017

133

1 reference

28 July 2017

1

1 reference

28 July 2017

357-366

1 reference

https://scigraph.springernature.com/pub.10.1007/s10549-012-1960-5

28 July 2017

0 references

cites work

Using visual displays to communicate risk of cancer to women from diverse race/ethnic backgrounds

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4039196

Women's decisions regarding tamoxifen for breast cancer prevention: responses to a tailored decision aid.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4039196

Association between cancer risk perception and screening behavior among diverse women

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4039196

21 June 2018

Cancer statistics, 2007

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4039196

Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4039196

Perceived risk of breast cancer among women at average and increased risk.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4039196

Tamoxifen for breast cancer chemoprevention: low uptake by high-risk women after evaluation of a breast lump

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4039196

Breast cancer risk reduction: strategies for women at increased risk

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4039196

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4039196

The role of numeracy in understanding the benefit of screening mammography

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4039196

Women's interest in chemoprevention for breast cancer

21 June 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-1960-5

Decision-making about tamoxifen in women at high risk for breast cancer: clinical and psychological factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-1960-5

Preferences of Women Evaluating Risks of Tamoxifen (POWER) study of preferences for tamoxifen for breast cancer risk reduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-1960-5

Acceptance of tamoxifen chemoprevention by physicians and women at risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-1960-5

Breast cancer risk reduction options: awareness, discussion, and use among women from four ethnic groups.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-1960-5

Women's misconceptions about cancer screening: implications for informed decision-making

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-1960-5

The use of cognitive testing to develop and evaluate CAHPS 1.0 core survey items. Consumer Assessment of Health Plans Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-1960-5

Patient reluctance toward tamoxifen use for breast cancer primary prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-1960-5

Treatment Decision Making Among Chinese Women with DCIS

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-1960-5

10.1007/S10549-012-1960-5

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

28 July 2017

0 references

1 reference

28 July 2017

1 reference